Matches in SemOpenAlex for { <https://semopenalex.org/work/W1591841128> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- W1591841128 endingPage "119" @default.
- W1591841128 startingPage "116" @default.
- W1591841128 abstract "RESUMENEl equivalente total de levodopa (L-dopa) se utiliza paracomparar de manera directa las dosis de medicamentosantiparkinsonicos distintos. El calculo de esteequivalente, por lo general proviene de las reportadasen distintos estudios, por desgracia hasta el momentono existe una ecuacion utilizada de forma uniforme enla literatura mundial. En el caso de utilizarse con lafinalidad de medir cambios porcentuales no presentagrandes inconvenientes; sin embargo, si se deseacomparar directamente la dosis total entre pacientescon distintos medicamentos o bien correlacionarla conalgun evento es posible presentar sesgos considerables.Material y metodos: se comparo el equivalente total delevodopa en 85 pacientes con enfermedad de Parkinsonconsecutivos mediante metodos disponibles en laliteratura mundial y se desarrollo un metodo para elcalculo del equivalente total de levodopa basado enlos mismos. Resultados: los distintos factores de conver-sion presentan diferencias en estadistica significativasentre las distintas ecuaciones. Conclusion: la unificacionen los factores de conversion permite una mayorcomparabilidad entre estudios que involucren el calculodel equivalente de dosis diaria de levodopa.Palabras clave: enfermedad de Parkinson, equivalen-tes de levodopa, dosis diaria de equivalentes delevodopa.LEVODOPA EQUIVALENCE UNITS CALCULATIONIN PARKINSON’S DISEASEABSTRACTTotal levodopa dose equivalence is used to directlycompare the dose of different antiparkinsonictreatments. Calculation of this equivalence usually isprovided by different researchers and unfortunately thereis not a unified equation on the medial literature. Usingthose equations to compare changes in proportionsdoes not present any inconvenience but if the maingoal is to directly compare total dose between patientsreceiving different treatments or to search correlationswith the dose bias can then arise. Methods: totallevodopa dose equivalence was compared in 85consecutive Parkinson’s disease patients using differentformulas available in the literature as well as with a newone which was derived from them. Results: statisticalsignificant differences were found between the methods.Conclusion: By unifying the conversion factors in theequation a better comparability could be achieve instudies involving the calculation of total levodopa doseequivalence.Key words: Parkinson’s disease, levodopa equivalents,levodopa equivalent daily dose.l calculo de dosis diaria de equivalente delevodopa (LEDD) o unidades de equivalenciade levodopa (LEU) se utiliza para cuantificar loscambios en el tratamiento de medicamentos antipar-" @default.
- W1591841128 created "2016-06-24" @default.
- W1591841128 creator A5011475043 @default.
- W1591841128 creator A5028141344 @default.
- W1591841128 creator A5041284655 @default.
- W1591841128 creator A5050004030 @default.
- W1591841128 date "2009-01-01" @default.
- W1591841128 modified "2023-09-27" @default.
- W1591841128 title "Cálculo de unidades de equivalencia de levodopa en enfermedad de Parkinson" @default.
- W1591841128 cites W2014166110 @default.
- W1591841128 cites W2059867556 @default.
- W1591841128 cites W2073755446 @default.
- W1591841128 cites W2086414180 @default.
- W1591841128 cites W2087565659 @default.
- W1591841128 cites W2181957723 @default.
- W1591841128 hasPublicationYear "2009" @default.
- W1591841128 type Work @default.
- W1591841128 sameAs 1591841128 @default.
- W1591841128 citedByCount "4" @default.
- W1591841128 countsByYear W15918411282013 @default.
- W1591841128 countsByYear W15918411282014 @default.
- W1591841128 countsByYear W15918411282015 @default.
- W1591841128 crossrefType "journal-article" @default.
- W1591841128 hasAuthorship W1591841128A5011475043 @default.
- W1591841128 hasAuthorship W1591841128A5028141344 @default.
- W1591841128 hasAuthorship W1591841128A5041284655 @default.
- W1591841128 hasAuthorship W1591841128A5050004030 @default.
- W1591841128 hasConcept C126322002 @default.
- W1591841128 hasConcept C138885662 @default.
- W1591841128 hasConcept C15708023 @default.
- W1591841128 hasConcept C202444582 @default.
- W1591841128 hasConcept C2779134260 @default.
- W1591841128 hasConcept C2779734285 @default.
- W1591841128 hasConcept C2780069185 @default.
- W1591841128 hasConcept C2780304432 @default.
- W1591841128 hasConcept C33923547 @default.
- W1591841128 hasConcept C71924100 @default.
- W1591841128 hasConceptScore W1591841128C126322002 @default.
- W1591841128 hasConceptScore W1591841128C138885662 @default.
- W1591841128 hasConceptScore W1591841128C15708023 @default.
- W1591841128 hasConceptScore W1591841128C202444582 @default.
- W1591841128 hasConceptScore W1591841128C2779134260 @default.
- W1591841128 hasConceptScore W1591841128C2779734285 @default.
- W1591841128 hasConceptScore W1591841128C2780069185 @default.
- W1591841128 hasConceptScore W1591841128C2780304432 @default.
- W1591841128 hasConceptScore W1591841128C33923547 @default.
- W1591841128 hasConceptScore W1591841128C71924100 @default.
- W1591841128 hasIssue "2" @default.
- W1591841128 hasLocation W15918411281 @default.
- W1591841128 hasOpenAccess W1591841128 @default.
- W1591841128 hasPrimaryLocation W15918411281 @default.
- W1591841128 hasRelatedWork W2064996887 @default.
- W1591841128 hasVolume "14" @default.
- W1591841128 isParatext "false" @default.
- W1591841128 isRetracted "false" @default.
- W1591841128 magId "1591841128" @default.
- W1591841128 workType "article" @default.